Who are minoxidil 5% solution's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): metformin, glyburide and glargine, Minoxidil Topical, Minoxidil 5% Topical Solution, Minoxidil lotion 1%, Minoxidil 5 % Topical Spray, Sigmart (nicorandil).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/minoxidil-5-solution.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

minoxidil 5% solution — Competitive Intelligence Brief

minoxidil 5% solution (minoxidil 5% solution) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Potassium channel opener. Area: Dermatology.

marketed Potassium channel opener ATP-sensitive potassium channels Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

minoxidil 5% solution (minoxidil 5% solution) — Allergan. Minoxidil is a potassium channel opener that increases blood flow to hair follicles and prolongs the anagen (growth) phase of the hair cycle.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
minoxidil 5% solution TARGET	minoxidil 5% solution	Allergan	marketed	Potassium channel opener	ATP-sensitive potassium channels
metformin, glyburide and glargine	metformin, glyburide and glargine	The University of Texas Health Science Center at San Antonio	marketed	Combination antidiabetic therapy (biguanide + sulfonylurea + basal insulin)	Multiple: AMP-activated protein kinase (metformin), ATP-sensitive potassium channels (glyburide), insulin receptor (glargine)
Minoxidil Topical	Minoxidil Topical	Dr. dr. Lili Legiawati, SpKK(K)	marketed	Potassium channel opener	ATP-sensitive potassium channels
Minoxidil 5% Topical Solution	Minoxidil 5% Topical Solution	Triple Hair Inc	marketed	Potassium channel opener	ATP-sensitive potassium channels (KATP)
Minoxidil lotion 1%	Minoxidil lotion 1%	Mae Fah Luang University Hospital	marketed	Potassium channel opener / topical hair growth stimulant	ATP-sensitive potassium channels
Minoxidil 5 % Topical Spray	Minoxidil 5 % Topical Spray	Sheikh Zayed Federal Postgraduate Medical Institute	marketed	Potassium channel opener / Topical hair growth stimulant	ATP-sensitive potassium channels (KATP)
Sigmart (nicorandil)	Sigmart (nicorandil)	Merck KGaA, Darmstadt, Germany	marketed	Potassium channel opener with nitrate-like properties	ATP-sensitive potassium channels (KATP)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). minoxidil 5% solution — Competitive Intelligence Brief. https://druglandscape.com/ci/minoxidil-5-solution. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab